Skip to main content
ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada flag Canada · Delayed Price · Currency is CAD
0.7800
-0.0200 (-2.50%)
Mar 31, 2025, 4:00 PM EST

ZYUS Life Sciences Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-36.55-42.59-24.66-23.46-25.09
Depreciation & Amortization
2.983.113.062.521.36
Other Amortization
--0.981.260.06
Loss (Gain) From Sale of Assets
-----0.24
Asset Writedown & Restructuring Costs
22.7722.772.09-3.24
Stock-Based Compensation
0.560.270.110.621.56
Other Operating Activities
-2.993.256.220.030.03
Change in Accounts Receivable
0.12-0.350.110.330.68
Change in Inventory
-0.15-0.020.45-0.17-4.87
Change in Accounts Payable
2.86-5.122.341.933.71
Change in Other Net Operating Assets
3.020.67-0.270.08-1.12
Operating Cash Flow
-7.39-18.01-9.57-16.86-20.68
Capital Expenditures
-0.24-0.28-0.56-4.99-5.45
Sale of Property, Plant & Equipment
----0.29
Cash Acquisitions
-4.92-0.03--
Sale (Purchase) of Intangibles
----0-0.52
Investing Cash Flow
-0.244.64-0.59-4.99-5.68
Short-Term Debt Issued
-0.353.04--
Long-Term Debt Issued
-20.896.7611.6310.99
Total Debt Issued
0.721.249.811.6310.99
Short-Term Debt Repaid
--3.29-0.1--
Long-Term Debt Repaid
--0.82-0.24-0.03-0.45
Total Debt Repaid
-3.36-4.11-0.34-0.03-0.45
Net Debt Issued (Repaid)
-2.6617.149.4511.610.54
Issuance of Common Stock
3.31-0.183.010.16
Financing Cash Flow
0.6617.149.6314.6114.68
Net Cash Flow
-6.973.77-0.54-7.24-11.68
Free Cash Flow
-7.63-18.29-10.13-21.85-26.13
Free Cash Flow Margin
-1687.83%-5211.68%-3400.67%-10553.14%-
Free Cash Flow Per Share
-0.11-0.33-0.26-0.43-0.54
Cash Interest Paid
0.280.230.110.90.13
Levered Free Cash Flow
-2.63-14.89-5.66-12.36-
Unlevered Free Cash Flow
-2.28-12.85-2.38-11.45-
Change in Net Working Capital
-6.233.83-4.47-3.37-
Updated Nov 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.